Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (5068)	12/9/1997 10:35:00 AM
From: biofisher	Respond to of 17367

I subscribe to all the newsletters under discussion. Each has its strengths and weaknesses. I've made the most money from Sturza long recomendations. Have lost much on his shorts but they were mainly hedges in what has been a great bull market. I'll judge MTSL by what happens to IMGN - I'm in the red big time but Jim hangs in there - I think he may be too trusting of management. I like MM as he adds useful perspective on both stocks and market. Strongly recommend NeuroInvestment letter for its in depth coverage of stocks and neuro-disease/treatment.